JNJ vs NOW: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and ServiceNow, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
ServiceNow, Inc. · Technology
$139.82
+16.2% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
NOW has more upside to fair value
(+16.2%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
NOW |
| Current Price |
$270.68 |
$139.82 |
| Fair Value Estimate |
$286.05 |
$162.50 |
| Upside to Fair Value |
+5.7%
|
+16.2%
|
| Market Cap |
$652.3B |
$144.6B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
43.1x
|
| Price / Sales |
6.7x
|
9.8x
|
| Price / FCF |
35.3x
|
31.5x
|
| Revenue Growth YoY |
+6.6%
|
+24.0%
|
| Gross Margin |
67.9%
|
74.8%
|
| Operating Margin |
26.8%
|
11.4%
|
| Return on Equity |
25.7%
|
13.8%
|
| Dividend Yield |
1.95% |
0% |
| FCF Yield |
2.83%
|
3.17%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
ServiceNow provides a cloud-based enterprise workflow platform spanning IT service management, operations, employee workflows, CRM, AI orchestration and security. Business quality is high because its common data model, deeply embedded workflows and cross-department deployments create meaningful switching costs, while roughly 90% of the Fortune 500 use the platform and more than 85 billion workflo…
Accumulation Zones
| Metric |
JNJ |
NOW |
| Zone Low |
$214.54 |
$121.88 |
| Zone High |
$243.14 |
$138.12 |
| In Buy Zone? |
No
|
No
|